Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
04/01/1998 | EP0831899A1 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (rhdv)] compositions and uses |
04/01/1998 | EP0831895A1 Tumor associated epitopes |
04/01/1998 | EP0831880A1 Antibody and antibody fragments for inhibiting the growth of tumors |
04/01/1998 | EP0831866A1 Pineal gland specific gene-1 |
04/01/1998 | EP0831714A1 Monospecific antibodies and methods using them |
04/01/1998 | EP0733208B1 Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction |
04/01/1998 | EP0668930A4 A method of identifying ligands and antagonists of ligands. |
04/01/1998 | EP0637318B1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
04/01/1998 | CN1177982A System for the expression of heterologous antigens as fusion proteins |
04/01/1998 | CN1177909A Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
04/01/1998 | CN1177640A Improved heat-stable DNA polymerase |
03/31/1998 | US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide) |
03/31/1998 | US5734037 DNA encoding the human cytokine, interleukin-9 |
03/31/1998 | US5734035 Nematode vaccine |
03/31/1998 | US5734026 Process for manufacturing crystals of growth hormone and crystals thereby obtained |
03/31/1998 | US5734019 Hepatitis C virus antigen polypeptide, production method therefor, and antibody detection method |
03/31/1998 | US5734016 Genetic engineering |
03/31/1998 | US5734014 Polypeptide |
03/31/1998 | US5734013 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same |
03/31/1998 | US5733876 Method of inhibiting angiogenesis |
03/31/1998 | US5733875 Epilepsy |
03/31/1998 | US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
03/31/1998 | US5733782 Methods and compositions for high protein production from non-native DNA |
03/31/1998 | US5733778 Vaccines, medical diagnosis |
03/31/1998 | US5733771 cDNAs encoding minor ampullate spider silk proteins |
03/31/1998 | US5733768 Amyloid precursor protein protease |
03/31/1998 | US5733757 Aldol condensations for antibodies |
03/31/1998 | US5733745 Pure genetic engineered protein |
03/31/1998 | US5733744 Binary BAC vector |
03/31/1998 | US5733742 Polyclonal immunoglobulin fab fragments |
03/31/1998 | US5733726 Cytotoxicity-based genetic selection system (TOXSEL) |
03/31/1998 | US5733720 Dna-transfected cell line susceptible to infection by herpes virus which is stably transformed with chimeric gene comprising herpes virus inducible promoter and gene coding for an enzyme, the expression of which is dependent on virus |
03/31/1998 | US5733548 Stimulating t-cell response |
03/31/1998 | US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
03/31/1998 | CA1339792C Purification of hepatitis proteins |
03/31/1998 | CA1339791C Human nerve growth factor |
03/26/1998 | WO1998012563A1 Method to detect dirofilaria immitis infection |
03/26/1998 | WO1998012344A1 Human tumor necrosis factor receptor-like genes |
03/26/1998 | WO1998012334A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
03/26/1998 | WO1998012331A1 Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
03/26/1998 | WO1998012329A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
03/26/1998 | WO1998012326A1 Hedgehog interacting proteins and uses related thereto |
03/26/1998 | WO1998012325A1 Human gtp binding protein gamma-3 |
03/26/1998 | WO1998012323A1 Nucleic acid encoding congenital heart disease protein and products related thereto |
03/26/1998 | WO1998012322A1 Bone morphogenetic protein-16 (bmp-16) compositions |
03/26/1998 | WO1998012315A1 Cell-free translational extract from eukaryotic cells that have grown in monolayers |
03/26/1998 | WO1998012306A1 Hematopoietic stem cells and methods for generating such cells |
03/26/1998 | WO1998012300A1 Novel host cells and methods of producing proteins |
03/26/1998 | WO1998012224A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes |
03/26/1998 | WO1998012220A2 Novel tumor proteins |
03/26/1998 | WO1998012207A1 High level expression of proteins |
03/26/1998 | WO1998012204A1 Human b-cell translocation genes-2 and 3 |
03/26/1998 | WO1998011918A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation |
03/26/1998 | WO1997049832A3 Method of identifying cytochrome p450 |
03/26/1998 | WO1997048724A3 Human metabotropic glutamate receptor |
03/26/1998 | WO1997048370A3 Vaccines comprising synthetic genes |
03/26/1998 | WO1997040063A3 Pathogenic escherichia coli associated protein espa |
03/26/1998 | CA2267288A1 Hematopoietic stem cells and methods for generating such cells |
03/26/1998 | CA2266684A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation |
03/26/1998 | CA2266585A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes |
03/26/1998 | CA2266428A1 Method to detect dirofilaria immitis infection |
03/26/1998 | CA2266425A1 Human b-cell translocation genes-2 and 3 |
03/26/1998 | CA2266341A1 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
03/26/1998 | CA2266339A1 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
03/26/1998 | CA2264542A1 Human gtp binding protein gamma-3 |
03/26/1998 | CA2263818A1 Novel tumor proteins |
03/26/1998 | CA2236165A1 Novel polypeptide from haemophilus paragallinarum and process for preparing the same |
03/25/1998 | EP0830456A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE |
03/25/1998 | EP0830450A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof |
03/25/1998 | EP0830376A1 Process for producing erythropoietin containing no animal proteins |
03/25/1998 | EP0830373A1 Cd6 ligand |
03/25/1998 | EP0830370A1 N-1-carboxyalkyl derivatives of lsd |
03/25/1998 | EP0830143A1 Use of leukemia inhibitory factor and endothelin antagonists |
03/25/1998 | EP0830139A1 Modified myelin protein molecules |
03/25/1998 | EP0830138A1 Use of fibroblast growth factors to stimulate bone growth |
03/25/1998 | EP0830130A1 Tnf-alpha converting enzyme |
03/25/1998 | EP0679094B1 Compounds for targeting |
03/25/1998 | EP0584166B1 Yeast promoter and use thereof |
03/25/1998 | EP0461165B2 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site |
03/25/1998 | CN1177380A DNA integration by transposition |
03/25/1998 | CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof |
03/25/1998 | CN1177302A Lymphotoxin- |
03/25/1998 | CN1037857C Method for preparing peptide derivatives by using black chain mould |
03/25/1998 | CN1037844C Tnf-muteins |
03/24/1998 | US5731428 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
03/24/1998 | US5731427 Nucleic acids encoding a gap-associated protein |
03/24/1998 | US5731284 Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product |
03/24/1998 | US5731200 Isolated nucleic acid encoding receptor-like TGF-β1 binding protein |
03/24/1998 | US5731195 Specified amino acid sequences |
03/24/1998 | US5731190 Penton base protein and methods of using same |
03/24/1998 | US5731183 Bacillus-derived transglutaminase |
03/24/1998 | US5731170 DNA encoding a growth factor specific for epithelial cells |
03/24/1998 | US5731168 Method for making heteromultimeric polypeptides |
03/24/1998 | US5731166 Recombinant production of chemotactic CP-10 polypeptides and therapeutic methods using them |
03/24/1998 | US5731154 Method for detecting human contactin |
03/24/1998 | US5731151 Tuberculosis vaccine |
03/24/1998 | US5731149 Antibiotic cryptdin peptides and methods of their use |
03/24/1998 | US5730982 Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof |
03/24/1998 | US5730981 Monoclonal anti-ganglioside antibody and its preparation |
03/24/1998 | US5730980 Methods and compositions for ameliorating the symptoms of sepsis |